Xtant Medical Inc.

AMEX: XTNT · Real-Time Price · USD
0.65
-0.00 (-0.05%)
At close: Aug 15, 2025, 9:42 AM

Xtant Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
35.41M 32.9M 31.51M 27.94M 29.94M 27.87M 28.11M 25.02M 20.23M 17.94M 15.27M 14.46M 15.28M 12.96M 13.97M 13.78M 14.97M 12.54M
Cost of Revenue
11.13M 12.66M 15.49M 11.63M 11.36M 10.57M 10.97M 9.69M 7.77M 7.41M 6.96M 6.57M 6.9M 5.4M 6.28M 6.59M 5.46M 4.45M
Gross Profit
24.28M 20.24M 16.02M 16.31M 18.58M 17.3M 17.14M 15.33M 12.46M 10.54M 8.31M 7.9M 8.37M 7.56M 7.69M 7.19M 9.52M 8.09M
Operating Income
4.62M 1.06M -1.88M -3.78M -2.95M -3.47M -3.81M -3.38M -1.39M -1.58M -1.72M -1.9M -1.3M -1.83M -1.91M -1.45M -491K -5K
Interest Income
n/a n/a n/a n/a n/a n/a 16K 48K n/a 86K 31K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
3.81M 33K -3.14M -4.96M -3.83M -4.33M -3.73M 6.93M -2.18M -2.06M -2.19M -2.34M -1.7M -2.19M -2.38M -1.77M -690K -6K
Net Income
3.55M 58K -3.17M -5.02M -3.86M -4.4M -4.3M 9.23M -2.19M -2.08M -2.21M -2.35M -1.71M -2.21M -2.28M -1.8M -733K -29K
Selling & General & Admin
19.09M 18.74M 17.38M 19.38M 20.89M 20.25M 20.45M 18.23M 13.67M 11.94M 9.8M 9.57M 9.43M 9.18M 9.46M 8.37M 9.76M 7.88M
Research & Development
566K 443K 522K 701K 636K 527K 492K 490K 180K 174K 232K 229K 241K 213K 151K 262K 243K 214K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
19.66M 19.18M 17.91M 20.08M 21.53M 20.77M 20.94M 18.72M 13.85M 12.11M 10.03M 9.8M 9.67M 9.39M 9.61M 8.64M 10.01M 8.1M
Interest Expense
1M 1.04M 1.13M 1.2M 992K 835K 818K 760K 786K 575K 495K 440K 397K 359K 466K 329K 199K 1K
Selling & Marketing Expenses
11.62M 11.2M 11.68M 11.89M 13.18M 12.46M 11.58M 11.09M 8.72M 7.05M 5.83M 5.84M 5.64M 5.21M 5.31M 5.27M 5.59M 4.86M
Cost & Expenses
30.79M 31.84M 33.4M 31.71M 32.89M 31.34M 31.91M 28.4M 21.62M 19.52M 16.99M 16.36M 16.58M 14.79M 15.88M 15.22M 15.47M 12.55M
Income Tax Expense
255K 25K 21K 62K 36K 68K 577K 2.3M 13K 13K 21K 13K 13K 23K -95K 30K 43K 23K
Shares Outstanding (Basic)
139.31M 143.56M 138.98M 135.1M 130.27M 130.2M 130.02M 128.14M 108.9M 108.89M 108.34M 93.28M 85.5M 87.19M 87.03M 86.76M 86.71M 81.25M
Shares Outstanding (Diluted)
148.57M 143.34M 138.98M 135.1M 130.27M 130.2M 130.02M 135.66M 108.9M 108.89M 108.34M 93.28M 87.31M 87.19M 87.03M 86.76M 86.71M 81.25M
EPS (Basic)
0.03 0.00 -0.02 -0.04 -0.03 -0.03 -0.03 0.07 -0.02 -0.02 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.01 -0.00
EPS (Diluted)
0.02 0.00 -0.02 -0.04 -0.03 -0.03 -0.03 0.07 -0.02 -0.02 -0.02 -0.03 -0.02 -0.03 -0.03 -0.02 -0.01 -0.00
EBITDA
5.98M 2.14M -862K -2.69M -1.83M -2.49M -1.89M 8.57M -588K -1.02M -1.37M -1.53M -982K -1.55M -1.62M -1.14M -133K 370K
EBIT
4.81M 1.06M -2.01M -3.76M -2.83M -3.5M -2.91M 7.69M -1.39M -1.49M -1.69M -1.9M -1.3M -1.83M -1.91M -1.45M -491K -5K
Depreciation & Amortization
1.17M 1.07M 1.15M 1.07M 998K 1M 1.02M 883K 804K 473K 323K 372K 318K 281K 292K 313K 358K 378K